Future studies should invest efforts in identifying SAA-receptors and the signaling pathways triggered by SAA in gliomas, and in investigating the effects of SAA on the cytoskeleton major protein and on invasiveness using more complex assays, such as the invasion assay in brain slice model [57]. Here, SAA2 is linked to central nervous system cancer.